Renal failure during chemotherapy: renal biopsy for assessing subacute nephrotoxicity of pemetrexed
Abstract Background Pemetrexed, a multitargeted antifolate cytotoxic agent, is currently used primarily in combination with cisplatin for metastatic non-small cell lung cancer and for malignant mesothelioma. Acute renal toxicity of pemetrexed has been recently described with polychemotherapy, in whi...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-11-01
|
Series: | BMC Cancer |
Online Access: | http://link.springer.com/article/10.1186/s12885-017-3705-7 |